In:
Bioethics, Wiley, Vol. 11, No. 3-4 ( 1997-07), p. 348-365
Abstract:
In the aftermath of allegations of the misuse of human eggs in the United States, questions are being raised about whether profitable reproductive services should continue to function in a free market under the aegis of physicians or should be regulated. Other countries in which reproductive technologies are employed to a significant degree have developed regulations governing their use, many as a result of recommendations made by inter‐disciplinary commissions that solicited public input. Policy makers in the United States have been reluctant to regulate reproductive technologies, however, because their use is politically controversial, they want to whittle down government, some do not consider infertility an illness, and some believe regulation would interfere with the right to reproduce. Yet the unfettered use of reproductive technologies can create such harms as lack of informed consent, providing procedures not medically indicated for financial gain, practice by unqualified personnel, injury to patients and donors, failure to screen donated gametes, and inadequate medical record keeping. Americans place special value on the welfare of children and those who bring them into the world. Such values can outweigh individual procreative liberty when new reproductive technologies are at issue. Although the optimal course would be to establish a regulatory body to govern reproductive technologies, this is not politically feasible now. The newly established National Bioethics Advisory Commission provides a forum in which issues surrounding reproductive technologies should be addressed at this time in the United States.
Type of Medium:
Online Resource
ISSN:
0269-9702
,
1467-8519
DOI:
10.1111/biot.1997.11.issue-3-4
DOI:
10.1111/1467-8519.00075
Language:
English
Publisher:
Wiley
Publication Date:
1997
detail.hit.zdb_id:
1480658-7
SSG:
0
SSG:
12
SSG:
1
SSG:
5,1
Permalink
